
Episode #32
He was a surgeon. Now he’s CEO of a robotics startup | David Bell, Remedy Robotics
As a cardiac surgery trainee in Sydney, David Bell saw how much a stroke patient’s chances of recovery depended on their postcode. If they lived in Sydney and got treatment quickly, their chances of recovery could be 75-80%. But in much of the developing world where treatment options were often far more limited, it could be as low as 10%. Today, David is cofounder and CEO of Remedy Robotics, a startup with the goal of making endovascular surgery – the catheter-based treatment for strokes like these – available to anyone who needs it, wherever they live. The need is enormous: stroke is the world's second leading cause of death and a leading cause of disability, and every hour of delay makes it less likely a patient will live independently again. Yet only about 3% of the world has access to the kind of care that lets patients not just survive a stroke, but get back to something like normal life. Remedy Robotics have built a robot that is designed to be operated by a surgeon remotely. The aim is that a specialist in Sydney could one day treat a stroke patient in Suva. Remedy has already run the first fully robotic endovascular procedure in a human, as well as procedures on four patients fully remotely, in Toronto. In this episode, Kate Glazebrook sits down with David to talk about his experience going from surgeon to startup founder, the nuanced details about how hospitals decide which technology to invest in, how remaining in stealth caused Remedy Robotics some challenges when it came to recruiting talent early on, and plenty more.






